Fusade T
Centre Laser, 23 Rue de Saint-Pétersbourg, Paris, France.
Br J Dermatol. 2008 Jan;158(1):84-7. doi: 10.1111/j.1365-2133.2007.08194.x. Epub 2007 Oct 4.
Xanthelasma palpebrarum (xanthelasma) is a common disease involving the eyelids. It consists of yellowish plaques of esterified cholesterol situated in the middle and superficial layers of the dermis. Many techniques, including laser treatments, have been proposed to destroy these lesions. A preliminary study demonstrated the efficacy of 1064-nm Q-switched Nd:YAG laser in treating xanthelasma.
To present the results of a prospective study using 1064-nm Q-switched Nd:YAG laser to treat xanthelasma.
Thirty-eight lesions in 11 patients were treated.
The results observed after a single treatment by Q-switched Nd:YAG laser were scored as good or excellent in eight patients, i.e. for 26 of 38 lesions.
The treatment of xanthelasma by 1064-nm Q-switched Nd:YAG laser is a valuable treatment option to eliminate lesions, with rapid and good quality healing. The absence of any associated skin destruction allows treatment to be repeated when necessary.
睑黄瘤是一种累及眼睑的常见疾病。它由位于真皮中层和浅层的酯化胆固醇淡黄色斑块组成。已经提出了许多技术,包括激光治疗,来破坏这些病变。一项初步研究证明了1064纳米调Q Nd:YAG激光治疗睑黄瘤的有效性。
介绍一项使用1064纳米调Q Nd:YAG激光治疗睑黄瘤的前瞻性研究结果。
对11例患者的38个病变进行了治疗。
调Q Nd:YAG激光单次治疗后,8例患者(即38个病变中的26个)的观察结果被评为良好或优秀。
1064纳米调Q Nd:YAG激光治疗睑黄瘤是一种消除病变的有价值的治疗选择,愈合迅速且质量良好。由于没有任何相关的皮肤破坏,必要时可重复治疗。